BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33652656)

  • 1. Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9.
    Berthelsen MF; Leknes SL; Riedel M; Pedersen MA; Joseph JV; Hager H; Vendelbo MH; Thomsen MK
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652656
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Skoulidis F; Goldberg ME; Greenawalt DM; Hellmann MD; Awad MM; Gainor JF; Schrock AB; Hartmaier RJ; Trabucco SE; Gay L; Ali SM; Elvin JA; Singal G; Ross JS; Fabrizio D; Szabo PM; Chang H; Sasson A; Srinivasan S; Kirov S; Szustakowski J; Vitazka P; Edwards R; Bufill JA; Sharma N; Ou SI; Peled N; Spigel DR; Rizvi H; Aguilar EJ; Carter BW; Erasmus J; Halpenny DF; Plodkowski AJ; Long NM; Nishino M; Denning WL; Galan-Cobo A; Hamdi H; Hirz T; Tong P; Wang J; Rodriguez-Canales J; Villalobos PA; Parra ER; Kalhor N; Sholl LM; Sauter JL; Jungbluth AA; Mino-Kenudson M; Azimi R; Elamin YY; Zhang J; Leonardi GC; Jiang F; Wong KK; Lee JJ; Papadimitrakopoulou VA; Wistuba II; Miller VA; Frampton GM; Wolchok JD; Shaw AT; Jänne PA; Stephens PJ; Rudin CM; Geese WJ; Albacker LA; Heymach JV
    Cancer Discov; 2018 Jul; 8(7):822-835. PubMed ID: 29773717
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
    Guibert N; Jones G; Beeler JF; Plagnol V; Morris C; Mourlanette J; Delaunay M; Keller L; Rouquette I; Favre G; Pradines A; Mazieres J
    Lung Cancer; 2019 Nov; 137():1-6. PubMed ID: 31518912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
    La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
    Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Bange E; Marmarelis ME; Hwang WT; Yang YX; Thompson JC; Rosenbaum J; Bauml JM; Ciunci C; Alley EW; Cohen RB; Langer CJ; Carpenter E; Aggarwal C
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31428721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
    Kim HR; Cho BC; Shim HS; Lim SM; Kim SK; Chang J; Kim DJ; Kim JH
    Lung Cancer; 2014 Mar; 83(3):374-82. PubMed ID: 24468202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.
    Facchinetti F; Bluthgen MV; Tergemina-Clain G; Faivre L; Pignon JP; Planchard D; Remon J; Soria JC; Lacroix L; Besse B
    Lung Cancer; 2017 Oct; 112():62-68. PubMed ID: 29191602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases.
    Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
    J Thorac Oncol; 2015 Mar; 10(3):531-4. PubMed ID: 25695224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRISPR/Cas9 Minipig-A Transgenic Minipig to Produce Specific Mutations in Designated Tissues.
    Berthelsen MF; Riedel M; Cai H; Skaarup SH; Alstrup AKO; Dagnæs-Hansen F; Luo Y; Jensen UB; Hager H; Liu Y; Callesen H; Vendelbo MH; Jakobsen JE; Thomsen MK
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.
    Regina S; Valentin JB; Lachot S; Lemarié E; Rollin J; Gruel Y
    Clin Chem; 2009 Oct; 55(10):1834-42. PubMed ID: 19661141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Resistance to Immune Checkpoint Blockade in an
    Kwack WG; Shin SY; Lee SH
    Onco Targets Ther; 2020; 13():8901-8905. PubMed ID: 32982282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less immune cell infiltration and worse prognosis after immunotherapy for patients with lung adenocarcinoma who harbored STK11 mutation.
    Wang H; Guo J; Shang X; Wang Z
    Int Immunopharmacol; 2020 Jul; 84():106574. PubMed ID: 32413741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma.
    Chen L; Engel BE; Welsh EA; Yoder SJ; Brantley SG; Chen DT; Beg AA; Cao C; Kaye FJ; Haura EB; Schabath MB; Cress WD
    J Thorac Oncol; 2016 Jun; 11(6):838-49. PubMed ID: 26917230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
    Cai H; Zhang B; Ahrenfeldt J; Joseph JV; Riedel M; Gao Z; Thomsen SK; Christensen DS; Bak RO; Hager H; Vendelbo MH; Gao X; Birkbak N; Thomsen MK
    Nat Commun; 2024 Mar; 15(1):2088. PubMed ID: 38453924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer.
    Sumbly V; Landry I
    Cureus; 2022 Jan; 14(1):e21078. PubMed ID: 35165542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
    Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
    Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Biton J; Mansuet-Lupo A; Pécuchet N; Alifano M; Ouakrim H; Arrondeau J; Boudou-Rouquette P; Goldwasser F; Leroy K; Goc J; Wislez M; Germain C; Laurent-Puig P; Dieu-Nosjean MC; Cremer I; Herbst R; Blons H; Damotte D
    Clin Cancer Res; 2018 Nov; 24(22):5710-5723. PubMed ID: 29764856
    [No Abstract]   [Full Text] [Related]  

  • 18. Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.
    Pécuchet N; Laurent-Puig P; Mansuet-Lupo A; Legras A; Alifano M; Pallier K; Didelot A; Gibault L; Danel C; Just PA; Riquet M; Le Pimpec-Barthes F; Damotte D; Fabre E; Blons H
    Oncotarget; 2017 Apr; 8(14):23831-23840. PubMed ID: 26625312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
    Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
    Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
    Su GH; Hruban RH; Bansal RK; Bova GS; Tang DJ; Shekher MC; Westerman AM; Entius MM; Goggins M; Yeo CJ; Kern SE
    Am J Pathol; 1999 Jun; 154(6):1835-40. PubMed ID: 10362809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.